로딩 중…
지수 로딩 중…
Altimmune, Inc.
ALT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.70+2.27%
2026-06-18
Price Chart
Altimmune, Inc.-60.18%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $525M |
| Revenue | $36000.00 |
| Net Income | $-91M |
| Total Assets | $336M |
| Net Assets | $284M |
| Value | |
| P/B | 1.85x |
| FCF Yield | -13.71% |
| Profitability | |
| ROE | -32.07% |
| ROA | -27.14% |
| Op. Margin | -269216.67% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 18.18% |
| Total Debt | $36M |
| FCF | $-72M |
| Cash | $98M |
| Current Ratio | 29.56x |
| Performance | |
| 1Y Return | -60.18% |
| 1M Return | -1.46% |
| From 52W High | -65.07% |
| 1Y MDD | -66.41% |
| Trading | |
| Volume | 9,004,256 shares |
| Trading Value | $24M |
| Per Share | |
| EPS | $-0.88 |
| BPS | $2.24 |